Opportunities and Challenges of the Therapies Targeting CNS Regeneration

Opportunities and Challenges of the Therapies Targeting CNS Regeneration

96,29 €*

lieferbar, sofort per Download

Falls Sie eine Lieferung außerhalb DE, AT oder CH wünschen, nutzen Sie bitte unser Kontaktformular für eine Anfrage.

The therapeutic options for the treatment of Multiple Sclerosis (MS) and other neurodegenerative and traumatic diseases such as spinal cord injury, Alzheimer's, Parkinson's disease, etc. have experienced enormous progress over recent years. Despite these encouraging developments, available therapies are only partially effective, and the ultimate goal is still far from being attained. Improved understanding of the cellular and molecular mechanisms of the pathogenesis of neurodegeneration and demyelination has led to a variety of new therapeutic targets and approaches. In addition to modulation of the inflammatory process (MS) and classical neuroprotection (stroke, AD), therapeutic approaches focusing on active remyelinization and neuronal regeneration have become increasingly important. Based on current concepts, thisbook summarizes new therapeutic approaches.

1;Preface;5 2;Contents;7 3;List of Editors and Contributors;9 4;1 New Strategies for CNS Repair;14 5;2 Heterogeneity of Multiple Sclerosis: Implications for Therapy Targeting Regeneration;24 6;3 The Neuroprotective Effect of Inflammation: Implications for the Therapy of Multiple Sclerosis;36 7;4 Fibroblast Growth Factors in Oligodendrocyte Physiology and Myelin Repair;52 8;5 White Matter Progenitor Cells Reside in an Oligodendrogenic Niche;73 9;6 At the Interface of the Immune System and the Nervous System: How Neuroinflammation Modulates the Fate of Neural Progenitors In Vivo;94 10;7 Remyelination and Restoration of Axonal Functionby Glial Cell Transplantation;126 11;8 Gene and Stem Cell Therapy for Autoimmune Demyelination;144 12;9 Novel Gene Therapeutic Strategiesfor Neurodegenerative Diseases;158 13;10 Measuring Injury and Repair of Myelin and Neurons in Multiple Sclerosis;183
ISBN 9783540276265
Artikelnummer 9783540276265
Medientyp E-Book - PDF
Copyrightjahr 2007
Verlag Springer-Verlag
Umfang 186 Seiten
Sprache Englisch
Kopierschutz Digitales Wasserzeichen